Abstract 298: Fibrate use in patients with type 2 diabetes [Poster Session III]

In conclusion, the prevalence of atherogenic dyslipidemia among patients with type 2 diabetes has increased significantly over the past decade. However, fibrate use in all patients with type 2 diabetes, including those specifically with atherogenic dyslipidemia, has remained constant throughout the observation period, despite lack of conclusive evidence supporting its use.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Tags: Poster Session III Source Type: research